Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics.

Citations & References

  • Authors: Rossi EA, Goldenberg DM, Cardillo TM, Stein R, Wang Y, Chang CH,
  • Journal: Cancer Res (2008) 68:8384-8392
  • Product Usage: (1) Analysis of complement-dependent cytotoxicity (CDC). (2) Labeling of chimeric anti-CD20 humanized antibodies for flow cytometric analysis of dissociation from Daudi or Raji cells.,Metabolic Activity, Fluorescence, Reduction
  • ID: PN67393
Catalog #s
F1241
F1242
F14218
F14242
F23915
V23110
Z25455
6a93188854e0be7204fc75b73ccfd39f_Citations